Neue Suche | Kongressdetail
Druckansicht
 
 

7th Drug Formulation, Solubility and Bioavailability

evvnt Platform / evvnt
-
26.03.2018 - 28.03.2018  Revere Hotel Boston Common, 200 Stuart Street, 02116 Boston, USA
Time: 8:00 am to 5:00 pm
 
Kongressthemen
When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation and delivery strategies to maximize bioavailability. ExL's 7th Drug Formulation, Solubility and Bioavailability conference helps you recognize the precise thresholds where an enabled formulation becomes necessary, as well as determine which method to use and how to predict and gauge its success.
Kongressorganizer (PCO)
Exl Events
Anmerkungen
Speakers: Rossitza Alargova Director, Formulations, INFINITY PHARMACEUTICALS, Gail Dempsey EOC and Director, Manufacturing Technologies, PIEDMONT ANIMAL HEALTH, Rakesh Dixit Vice President, RandD, Global Head, Biologics Safety, MEDIMMUNE
 

Anfragen und Anmeldung:

URLs: Brochure: https://go.evvnt.com/174423-1 Booking: https://go.evvnt.com/174423-2
Frau Alysha Parker
1 917 9320435
 
Kategorien
Innere Medizin
Sprache
Englisch
Kongressgebühr
USD 2.895,00
(Conference Only - Early Bird Pricing - Register by February 9, 2018: USD 1795, Conference + Seminar - Onsite Pricing: USD 2895)
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
Tel: +44 0207 3230 450
hello@evvnt.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Hilfswerk AustriaCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAMREF - African Medical and Research FoundationOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Helix - Forschung & Beratung WienSwiss Tropical and Public Health InstituteCenter of ExcellenceAnästhesie in Entwicklungsländern e. V.

Facebook

Sagen Sie uns Ihre professionelle Meinung

Zur Umfrage

Zur Umfrage